Flask in scientist hand and test tubes in rack

The shares of American Express Company (NYSE:AXP) has been pegged with a rating of Sector Perform by RBC Capital Mkts in its latest research note that was published on May 3rd, 2019. The research company has also assigned a $120 price target. RBC Capital Mkts wasn’t the only research firm that published a report of American Express Company, with other equities research analysts also giving their opinion on the stock. UBS advised investors in its research note published on April 29th, 2019, to Neutral the AXP stock. The stock had earned Overweight rating from Morgan Stanley when it published its report on April 25th, 2019. That day the Morgan Stanley set price target on the stock to $140. The stock was given Neutral rating by BofA/Merrill in its report released on March 14th, 2019, the day when the price target on the stock was placed at $122. Atlantic Equities was of a view that AXP is Overweight in its latest report on January 29th, 2019. BofA/Merrill thinks that AXP is worth Neutral rating. This was contained in the firm’s report on December 19th, 2018 in which the stock’s price target was also moved to $115.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 16 believe it has the potential for further growth, thus rating it as Hold while 7 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $121.59. The price of the stock the last time has raised by 32.13% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 57.07.

The shares of the company added by 0.56% during the trading session on Wednesday, reaching a low of $115.90 while ending the day at $117.66. During the trading session, a total of 2.68 million shares were traded which represents a 19.61% incline from the average session volume which is 3.34M shares. AXP had ended its last session trading at 117.01. American Express Company currently has a market cap of $98.95B, while its P/E ratio stands at 16.20, while its P/E earnings growth sits at 2.33, with a beta of 1.10. American Express Company debt-to-equity ratio currently stands at 6.00, while its quick ratio hovers at . AXP 52-week low price stands at $89.05 while its 52-week high price is $119.65.

The company in its last quarterly report recorded $2.01 earnings per share which is above the $1.99 predicted by most analysts. The American Express Company generated $10,364.00 million in revenue during the last quarter, which is slightly lower than the $10,494.90 million predicted by analysts. In the second quarter last year, the firm recorded $1.74 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 13.43%. American Express Company has the potential to record 7.27 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Desjardins published a research note on April 26th, 2019 where it informed investors and clients that Aurora Cannabis Inc. (NYSE:ACB) is now rated as Buy. UBS also rated ACB as Downgrade on April 29th, 2019, with its price target of $27 suggesting that ACB could down by -INF% from its current share price. It started the day trading at $8.79 and traded between $8.01 and $8.68 throughout the trading session.

A look at its technical shows that ACB’s 50-day SMA is 8.87 while its 200-day SMA stands at 7.38. The stock has a high of $12.52 for the year while the low is $3.90. The company’s P/E ratio currently sits at 40.19, while the P/B ratio is 2.52. At the moment, only of Aurora Cannabis Inc. shares were sold short. The company’s average trading volume currently stands at 28.05M shares, which means that the short-interest ratio is just 2.98 days. Over the past seven days, the company moved, with its shift of 1.05%. Looking further, the stock has raised 19.72% over the past 90 days while it gained 19.07% over the last six months.